Some temporary weight stabilization or small regain of two to five pounds commonly occurs during the switching period, particularly in weeks two through four
Kristyn Gumpper-Fedus, PhD, for refining a draft of the Figure into its final form
Understanding this context helps set expectations for eventual pharmaceutical Retatrutide coverage
Common adverse effects include nausea, vomiting, diarrhea, constipation, and abdominal pain, which typically improve over time as the body adjusts to treatment
Remove the syringe and gently swirl the vial until the powder dissolves completely
4-8 Weeks and Beyond: As semaglutide GLP-1 continues to work within the system, the most substantial appetite reduction typically occurs between 4 to 8 weeks of use